{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:51:51Z","timestamp":1792857111390,"version":"4.5.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Liver damage due to long-term viral infection, alcohol consumption, autoimmune decline, and other factors could lead to the gradual development of liver fibrosis. Unfortunately, until now, there has been no effective treatment for liver fibrosis. Mesenchymal stem cells, as a promising new therapy for liver fibrosis, can slow the progression of fibrosis by migrating to the site of liver injury and by altering the microenvironment of the fibrotic area.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>By including all relevant studies to date to comprehensively assess the efficacy of mesenchymal stem cells for the treatment of hepatic fibrosis and to explore considerations for clinical translation and therapeutic mechanisms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data sources included PubMed, Web of Science, Embase, and Cochrane Library, and were constructed until October 2023. Data for each study outcome indicator were extracted for comprehensive analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The overall meta-analysis showed that mesenchymal stem cells significantly improved liver function. Moreover, it inhibited the expression level of transforming growth factor-\u03b2 [SMD = 4.21, 95% CI (3.02,5.40)], which in turn silenced hepatic stellate cells and significantly reduced the area of liver fibrosis [SMD = 3.61, 95% CI (1.41,5.81)].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Several outcome indicators suggest that mesenchymal stem cells therapy is relatively reliable in the treatment of liver fibrosis. The therapeutic effect is cell dose-dependent over a range of doses, but not more effective at higher doses. Bone-marrow derived mesenchymal stem cells were more effective in treating liver fibrosis than mesenchymal stem cells from other sources.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p>Identifier CRD42022354768.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fbioe.2024.1424253","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T10:42:33Z","timestamp":1721644953000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Effectiveness and mechanisms of mesenchymal stem cell therapy in preclinical animal models of hepatic fibrosis: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Xuesong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","article-title":"Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis","volume":"40","author":"Abdel Aziz","year":"2007","journal-title":"Clin. Biochem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1080\/20477724.2022.2064795","article-title":"Human umbilical cord blood mesenchymal stem cells as a potential therapy for schistosomal hepatic fibrosis: an experimental study","volume":"117","author":"Abou Rayia","year":"2023","journal-title":"Pathog. Glob. Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.15283\/ijsc.2014.7.2.87","article-title":"Role of bone marrow mesenchymal stem cells in the treatment of CCL4 induced liver fibrosis in albino rats: a histological and immunohistochemical study","volume":"7","author":"Ahmed","year":"2014","journal-title":"Int. J. Stem Cells"},{"key":"B4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.21037\/sci.2018.07.04","article-title":"Haemostatic potential of human bone marrow-derived mesenchymal stromal cells in Wistar rats with carbon tetrachloride induced liver cirrhosis","volume":"5","author":"Aithal","year":"2018","journal-title":"Stem Cell Investig."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.jhep.2018.01.030","article-title":"Mesenchymal stromal cell therapy for liver diseases","volume":"68","author":"Alfaifi","year":"2018","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/meg.0b013e3283488b00","article-title":"Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells","volume":"23","author":"Amer","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ctr.12179","article-title":"Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study","volume":"27","author":"Amin","year":"2013","journal-title":"Clin. Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e6657","DOI":"10.1371\/journal.pone.0006657","article-title":"Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver","volume":"4","author":"Baertschiger","year":"2009","journal-title":"PLoS One"},{"key":"B9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1574888x11308020005","article-title":"Mesenchymal stem cells derived from Wharton\u2019s Jelly of the umbilical cord: biological properties and emerging clinical applications","volume":"8","author":"Batsali","year":"2013","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1002\/term.2161","article-title":"Liver extracellular matrix promotes BM-MSCs hepatic differentiation and reversal of liver fibrosis through activation of integrin pathway","volume":"11","author":"Bi","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1741-7015-10-56","article-title":"Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure","volume":"10","author":"Cao","year":"2012","journal-title":"BMC Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.lfs.2009.08.003","article-title":"Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis","volume":"85","author":"Chang","year":"2009","journal-title":"Life Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cbi.2018.12.006","article-title":"Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-\u03b21\/Smad and NOX4\/ROS pathways","volume":"299","author":"Cheng","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"B14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1182\/blood-2007-03-078774","article-title":"Immunogenicity of umbilical cord tissue derived cells","volume":"111","author":"Cho","year":"2008","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/gut.2006.111617","article-title":"Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential","volume":"57","author":"Di Bonzo","year":"2008","journal-title":"Gut"},{"key":"B16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.17179\/excli2016-645","article-title":"Effect of undifferentiated versus hepatogenic partially differentiated mesenchymal stem cells on hepatic and cognitive functions in liver cirrhosis","volume":"15","author":"Elberry","year":"2016","journal-title":"Excli J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3904\/kjim.2015.30.5.580","article-title":"Mesenchymal stem cell therapy for liver fibrosis","volume":"30","author":"Eom","year":"2015","journal-title":"Korean J. Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1097\/pai.0000000000000373","article-title":"Hepatocyte-like versus mesenchymal stem cells in CCl4-induced liver fibrosis","volume":"25","author":"Ewida","year":"2017","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/molecules25092020","article-title":"Preconditioning of adipose-derived mesenchymal stem-like cells with eugenol potentiates their migration and proliferation in vitro and therapeutic abilities in rat hepatic fibrosis","volume":"25","author":"Fathy","year":"2020","journal-title":"Molecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s12015-021-10313-9","article-title":"Comparative evaluation of anti-fibrotic effect of tissue specific mesenchymal stem cells derived extracellular vesicles for the amelioration of CCl4 induced chronic liver injury","volume":"18","author":"Gupta","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.3892\/etm.2017.5333","article-title":"Comparison of bone marrow-vs. adipose tissue-derived mesenchymal stem cells for attenuating liver fibrosis","volume":"14","author":"Hao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s13287-021-02468-6","article-title":"Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1\/Stat3 signaling","volume":"12","author":"He","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3892\/mmr.2014.1927","article-title":"Infusion of human umbilical cord-derived mesenchymal stem cells effectively relieves liver cirrhosis in DEN-induced rats","volume":"9","author":"Hong","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1089\/scd.2009.0485","article-title":"Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton\u2019s jelly of umbilical cord","volume":"19","author":"Hsieh","year":"2010","journal-title":"Stem Cells Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/jcmm.14115","article-title":"Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis","volume":"23","author":"Hu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbrc.2018.02.067","article-title":"Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis","volume":"497","author":"Jang","year":"2018","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.biomaterials.2016.06.054","article-title":"Laminin-511 and laminin-521-based matrices for efficient hepatic specification of human pluripotent stem cells","volume":"103","author":"Kanninen","year":"2016","journal-title":"Biomaterials"},{"key":"B28","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s13770-020-00274-4","article-title":"Infusion of human mesenchymal stem cells improves regenerative niche in thioacetamide-injured mouse liver","volume":"17","author":"Kao","year":"2020","journal-title":"Tissue Eng. Regen. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bj.2020.04.011","article-title":"Therapeutic effect of bone marrow mesenchymal stem cells in a rat model of carbon tetrachloride induced liver fibrosis","volume":"44","author":"Khalil","year":"2021","journal-title":"Biomed. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1038\/emm.2014.49","article-title":"Therapeutic effect of hepatocyte growth factor-secreting mesenchymal stem cells in a rat model of liver fibrosis","volume":"46","author":"Kim","year":"2014","journal-title":"Exp. Mol. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/hep.25722","article-title":"Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs","volume":"56","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13287-022-03041-5","article-title":"Stem cells for treatment of liver fibrosis\/cirrhosis: clinical progress and therapeutic potential","volume":"13","author":"Liu","year":"","journal-title":"Stem Cell Res. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41420-022-00846-4","article-title":"ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-\u03b2\/Smad signaling pathway","volume":"8","author":"Liu","year":"","journal-title":"Cell Death Discov."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e12872","DOI":"10.7717\/peerj.12872","article-title":"From hair to liver: emerging application of hair follicle mesenchymal stem cell transplantation reverses liver cirrhosis by blocking the TGF-\u03b2\/Smad signaling pathway to inhibit pathological HSC activation","volume":"10","author":"Liu","year":"","journal-title":"PeerJ"},{"key":"B35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13287-018-1122-8","article-title":"Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes","volume":"10","author":"Luo","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13287-023-03518-x","article-title":"Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis","volume":"14","author":"Lu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3748\/wjg.v22.i6.2092","article-title":"Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway","volume":"22","author":"Ma","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/liv.12228","article-title":"Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis","volume":"33","author":"Mohamadnejad","year":"2013","journal-title":"Liver Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1177\/1535370215627219","article-title":"Bone marrow-derived mesenchymal stem cells effectively regenerate fibrotic liver in bile duct ligation rat model","volume":"241","author":"Mohamed","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00441-017-2604-1","article-title":"Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4","volume":"369","author":"Mortezaee","year":"2017","journal-title":"Cell Tissue Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jcb.1174","article-title":"Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges","volume":"82","author":"Mueller","year":"2001","journal-title":"J. Cell Biochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s10020-022-00566-6","article-title":"Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats","volume":"28","author":"Nomura","year":"2022","journal-title":"Mol. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e16060","DOI":"10.7717\/peerj.16060","article-title":"Fluorofenidone alleviates liver fibrosis by inhibiting hepatic stellate cell autophagy via the TGF-\u03b21\/Smad pathway: implications for liver cancer","volume":"11","author":"Peng","year":"2023","journal-title":"PeerJ"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1111\/liv.14610","article-title":"Human amniotic stem cells improve hepatic microvascular dysfunction and portal hypertension in cirrhotic rats","volume":"40","author":"Pietrosi","year":"2020","journal-title":"Liver Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1634\/stemcells.2006-0515","article-title":"No contribution of multipotent mesenchymal stromal cells to liver regeneration in a rat model of prolonged hepatic injury","volume":"25","author":"Popp","year":"2007","journal-title":"Stem Cells"},{"key":"B47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1691\/ph.2011.9840","article-title":"A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin","volume":"66","author":"Qiao","year":"2011","journal-title":"Pharmazie"},{"key":"B48","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biocel.2015.09.003","article-title":"Mesenchymal stem cells: in vivo therapeutic application ameliorates carbon tetrachloride induced liver fibrosis in rats","volume":"68","author":"Raafat","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.clnu.2016.03.002","article-title":"Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress","volume":"35","author":"Shi","year":"2016","journal-title":"Clin. Nutr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s13287-020-01911-4","article-title":"Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis","volume":"11","author":"Su","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/s1465-3249(23)00302-x","article-title":"Mesenchymal stem\/stromal cells: MSC and exosome therapy for liver cirrhosis","volume":"25","author":"Terai","year":"2023","journal-title":"Cytotherapy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s1995-7645(14)60048-1","article-title":"Effect of bone marrow mesenchymal stem cells on the Smad expression of hepatic fibrosis rats","volume":"7","author":"Wang","year":"","journal-title":"Asian Pac J. Trop. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/s1995-7645(14)60097-3","article-title":"Effect of Rougan Huaqian granules combined with human mesenchymal stem cell transplantation on liver fibrosis in cirrhosis rats","volume":"7","author":"Wang","year":"","journal-title":"Asian Pac J. Trop. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13287-022-02754-x","article-title":"Mesenchymal stem cells protect against acetaminophen hepatotoxicity by secreting regenerative cytokine hepatocyte growth factor","volume":"13","author":"Wang","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"B57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/1479-5876-10-133","article-title":"Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats","volume":"10","author":"Wang","year":"2012","journal-title":"J. Transl. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e078362","DOI":"10.1136\/bmjopen-2023-078362","article-title":"Human umbilical cord-derived mesenchymal stem cells for the treatment of decompensated cirrhosis (MSC-DLC-1): a dose-escalation, phase I trial protocol","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"B59","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13287-021-02430-6","article-title":"Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis","volume":"12","author":"Xie","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13578-020-00480-6","article-title":"Mesenchymal stem cell therapy for liver disease: full of chances and challenges","volume":"10","author":"Yang","year":"","journal-title":"Cell Biosci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13578-020-00480-6","article-title":"Mesenchymal stem cell therapy for liver disease: full of chances and challenges","volume":"10","author":"Yang","year":"","journal-title":"Cell Biosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13287-019-1260-7","article-title":"Mesenchymal stem cells overexpressing hepatocyte nuclear factor-4 alpha alleviate liver injury by modulating anti-inflammatory functions in mice","volume":"10","author":"Ye","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1089\/scd.2020.0060","article-title":"Effect of human umbilical cord mesenchymal stem cells transfected with HGF on TGF-\u03b21\/smad signaling pathway in carbon tetrachloride-induced liver fibrosis rats","volume":"29","author":"Yin","year":"2020","journal-title":"Stem Cells Dev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.3748\/wjg.v23.i46.8152","article-title":"In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: therapeutic effect on liver fibrosis\/cirrhosis","volume":"23","author":"Zhang","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"109433","DOI":"10.1016\/j.intimp.2022.109433","article-title":"Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPAR\u03b3 in carbon tetrachloride-treated mice","volume":"113","author":"Zhang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1038\/s41419-018-1239-9","article-title":"Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl(4)-induced hepatocirrhosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"B67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-023-01788-4","article-title":"Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.3748\/wjg.v11.i22.3431","article-title":"Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats","volume":"11","author":"Zhao","year":"2005","journal-title":"World J. Gastroenterology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s13287-022-03042-4","article-title":"Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy","volume":"13","author":"Zheng","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"B70","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s13287-020-01935-w","article-title":"Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6685605","article-title":"Human umbilical cord mesenchymal stem cells ameliorate hepatic stellate cell activation and liver fibrosis by upregulating MicroRNA-455-3p through suppression of p21-activated kinase-2","volume":"2021","author":"Zhou","year":"2021","journal-title":"Biomed. Res. Int."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1424253\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T10:42:47Z","timestamp":1721644967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1424253\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":71,"alternative-id":["10.3389\/fbioe.2024.1424253"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2024.1424253","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"article-number":"1424253"}}